Universe Pharmaceuticals INC financial data

Symbol
UPC on Nasdaq
Location
265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone, Ji'an, Jiangxi, China
State of incorporation
China
Fiscal year end
September 30
Latest financial report
20-F - Q3 2023 - Jan 30, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.65M shares -83.2%
Common Stock, Shares, Outstanding 3.65M shares +0.58%
Common Stock, Value, Issued 68.4K USD +0.58%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 14.4M USD -17.9%
Inventory, Net 3.39M USD +18.1%
Assets, Current 33.5M USD -36.2%
Deferred Income Tax Assets, Net 657K USD -51.3%
Property, Plant and Equipment, Net 3.52M USD -15%
Intangible Assets, Net (Excluding Goodwill) 148K USD -7.99%
Assets 49.4M USD -29.8%
Accounts Payable, Current 7.76M USD -30.9%
Liabilities, Current 20.6M USD -11.3%
Liabilities 22.7M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.1M USD -687%
Retained Earnings (Accumulated Deficit) -2.94M USD -119%
Stockholders' Equity Attributable to Parent 26.7M USD -43.3%
Liabilities and Equity 49.4M USD -29.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 167M shares 0%
Common Stock, Shares, Issued 3.65M shares +0.58%
Common Stock, Par or Stated Value Per Share 0.02 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.86M USD -31.6%
Property, Plant and Equipment, Gross 9.88M USD -4.18%
Deferred Tax Assets, Operating Loss Carryforwards 590K USD -51.3%
Preferred Stock, Shares Authorized 100M shares
Additional Paid in Capital 29.3M USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares